Teva Pharma (TEVA) Sees Active Put Buying Ahead of Earnings Announcement Tomorrow BMC -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Wall Street mixed after Trump fires FBI head; Nasdaq hits record high
May 10, 2017 7:35 AM EDTBy Noel Randewich
(Reuters) - U.S. stocks were mixed on Wednesday as investors digested President Donald Trump's abrupt dismissal of his FBI chief as well as corporate earnings from Walt Disney and Nvidia.
The Dow Jones industrial average lost ground, while the Nasdaq closed at a record high.
Trump said he fired Federal Bureau of Investigation Director James Comey over his handling of an email scandal involving then-Democratic presidential nominee Hillary Clinton.
However, Comey had also been leading an investigation into whether Trump's 2016 presidential campaign colluded with Russia.
Wall Street viewed the... More
Allergan posts loss as it writes down Teva holdings
May 9, 2017 7:13 AM EDTBy Michael Erman and Natalie Grover
(Reuters) - Botox-maker Allergan Plc (NYSE: AGN) posted a first-quarter loss on Tuesday as it took a nearly $2 billion write-down on the value of its stake in Teva Pharmaceutical Industries (NYSE: TEVA), which has lost more than 40 percent of its value since last year.
Allergan sold its generics business Actavis to Teva in August 2016 for $33 billion in cash and 100 million shares of the Israeli generic drugmaker, worth around $5.3 billion at... More
